TABLE 1.
TMSW (%) | Inoculum size (CFU/ml) | Susceptibilitya | Minimal count (CFU/ml) | Final count (CFU/ml) | ABBC (log CFU/ml/h) |
---|---|---|---|---|---|
100 | 105 | − | <100 | 2.106 | 53 |
+ | <100 | 1.108 | 51 | ||
107 | − | <100 | 7.104 | 60 | |
+ | <100 | 6.108 | 56 | ||
109 | + | 2.104 | 5.107 | 44 | |
25 | 105 | − | <100 | 6.104 | 54 |
107 | − | 150 | 8.104 | 56 | |
109 | − | 103 | 3.104 | 53 | |
0 | 105 | − | <100 | 7.103 | 54 |
107 | − | <100 | 2.104 | 57 | |
109 | − | 600 | 1.104 | 51 |
Susceptibility is assessed at the end of the experiments. The populations that were mainly resistant to a marbofloxacin concentration of 0.128 μg/ml (+) or mainly susceptible to a concentration of 0.128 μg/ml (−) are noted.